Bo-heng O. Zhang
Xiamen, 361015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Circulating tumor DNA in peripheral blood may predict the efficacy of immune-targeted therapy in patients with hepatocellular carcinoma.
Journal: Clinics and research in hepatology and gastroenterology
Published: February 15, 2025
Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study.
Journal: Journal of hepatocellular carcinoma
Published: December 17, 2024
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.
Journal: Lancet (London, England)
Published: December 10, 2024
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: November 21, 2024
Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 10, 2024
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway.
Journal: Hepatology international
Published: December 17, 2023
A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing.
Journal: Frontiers in molecular biosciences
Published: December 07, 2022
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Journal: Liver cancer
Published: June 16, 2022
Development and preliminary verification of the evaluation system for clinical practice guidelines in China.
Journal: Chronic diseases and translational medicine
Published: June 10, 2019
A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study.
Journal: Journal of Cancer
Published: February 13, 2019
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
Journal: Journal for immunotherapy of cancer
Published: November 21, 2018
Last Updated: 09/26/2026